Injection Site Reactions on GLP-1 Medications: What Is Normal

Mild redness, slight stinging, or a small bump at the injection site are all considered normal reactions to GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound. These local reactions are listed in FDA prescribing labels for each drug and typically resolve within a few hours to days on their own without any treatment.

What Does Normal Look Like at the Injection Site?

FDA prescribing information for semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) identifies the following as commonly reported, expected local reactions:

• Redness (erythema): A pink or red flush around the needle entry point, usually fading within a few hours.
• Itching (pruritus): Mild itchiness directly at or just around the injection spot.
• Bruising: Small bruises from a nicked capillary; more common if you inject too quickly or skip pinching the skin.
• Swelling or a small bump: A pea-sized lump that appears immediately after injection, caused by the fluid pooling under the skin before it disperses.
• Pain or tenderness: Brief stinging during the injection or mild soreness for a day or two afterward.

In clinical trials for Wegovy, injection-site reactions occurred in roughly 6–11% of participants, compared with about 2% on placebo, according to the STEP 2 trial published in The Lancet (Davies et al., 2021). Most reactions were rated mild to moderate in severity.

How Long Do Injection Site Reactions Usually Last?

Why Do These Reactions Happen?

GLP-1 receptor agonists are injected subcutaneously — into the fatty layer just beneath the skin. A few factors explain why the body sometimes reacts locally:

• pH and formulation: The solution's acidity or preservatives (such as phenol in some pens) can mildly irritate surrounding tissue.
• Needle trauma: Even a thin 4–6 mm needle creates a micro-wound. The immune system responds with brief inflammation, which is a normal healing signal.
• Injection technique: Injecting too fast, using a bent needle, or not letting refrigerated medication come to room temperature first can all increase local irritation.
• Repeated site use: Injecting the same spot every week can lead to lipohypertrophy — a buildup of scar-like fatty tissue. The Frid et al. (2016) consensus paper in Mayo Clinic Proceedings found that lipohypertrophy from repeated injection at the same site impairs drug absorption, which can affect blood sugar or weight loss results.

How Can You Reduce Injection Site Reactions?

Several evidence-informed techniques can minimize discomfort and prevent abnormal reactions:

1. Rotate sites every week. Approved areas include the abdomen (at least 2 inches from the navel), outer thigh, and upper arm. Map out a rotation schedule so you never reuse the same exact spot two weeks in a row.
2. Let the pen warm up. Remove it from the refrigerator 15–30 minutes before injecting. Cold medication is a leading cause of stinging and bumps.
3. Clean and let skin dry. Inject after the alcohol swab has fully dried — wet alcohol under the skin increases burning.
4. Inject slowly and steadily. FDA labeling for auto-inject pens advises holding the pen in place for the full count (usually 5–10 seconds) after pressing the button to ensure complete delivery.
5. Use a new needle every time. Reusing needles causes microscopic barbs that tear tissue and increase bruising risk.
6. Avoid injecting into areas with active skin conditions, tattoos, scars, or stretch marks, as absorption may be unpredictable.

What Reactions Are Warning Signs?

While most site reactions are minor, a few signals should prompt prompt medical attention:

• Signs of infection: Increasing warmth, spreading redness (streaking), pus, or fever appearing 24–72 hours after injection.
• Allergic reaction: Widespread hives, swelling of the face, lips, tongue, or throat, or difficulty breathing. The Ozempic and Wegovy FDA labels list serious hypersensitivity reactions — including anaphylaxis — as a potential risk requiring immediate discontinuation.
• Persistent nodule: A hard lump remaining for more than 1–2 weeks may indicate lipohypertrophy or, rarely, a sterile abscess.
• Skin discoloration that spreads: Darkening or large areas of bruising beyond the immediate injection zone.

If you are unsure whether a reaction is within the normal range, photograph it and contact your prescriber's office with the image before your next injection.

Frequently Asked Questions

Injection site reactions are one of the most common concerns for people starting GLP-1 therapy, but the vast majority are minor and short-lived. Understanding what is expected — and knowing the red flags that are not — gives you the confidence to manage your weekly injections safely at home. If you are experiencing reactions that concern you, seem to be getting worse over time, or are interfering with your ability to stay on your medication, bring it up at your next appointment or call your prescriber's office sooner. Technique adjustments, a different injection site, or additional evaluation can usually resolve the issue quickly.